Streetbeat News

Stock Prices

HD

WMT

Walmart reported strong fiscal second quarter results, surpassing Wall Street estimates for sales and profits, and raised its full-year outlook. In contrast, Home Depot warned of slow sales. Walmart's performance suggests consumer health is stabilizing, with significant growth in e-commerce and comparable sales.

Portfolio Pulse from Upwallstreet

August 20, 2024 | 1:23 pm

COSM

Cosmos Health reported a Q2 EPS of $(0.15), missing the $(0.14) estimate, and sales of $13.21M, missing the $14.55M estimate. This represents a significant decrease in earnings compared to the previous year, despite a slight increase in sales.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 1:22 pm

AUUD

Auddia Inc. (NASDAQ:AUUD) shares surged by 47.8% following the launch of faidr 3.1, which includes product improvements aimed at enhancing user metrics and increasing subscription revenue. The company focuses on converting consumer interest into significant revenue through new capabilities and features.

Portfolio Pulse from Nabaparna Bhattacharya

August 20, 2024 | 1:19 pm

ASTS

CLOV

INTC

LOT

LUNR

MADE

NVDA

RKLB

TSLA

WAY

The article lists the top 10 trending stocks on WallStreetBets as of August 20, 2024, according to Swaggy Stocks. The stocks mentioned are NVDA, ASTS, LUNR, RKLB, WAY, MADE, CLOV, TSLA, INTC, and LOT.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 1:18 pm

HALO

Halozyme Therapeutics (NYSE:HALO) has seen a 3.46% increase in its short percent of float, now at 9.57%. This indicates a bearish sentiment, although it remains below the peer group average of 12.43%.

Portfolio Pulse from Benzinga Insights

August 20, 2024 | 1:15 pm

CIEN

Ciena's short interest has increased by 6.13%, with 4.41 million shares sold short, representing 3.98% of its float. This is below the peer group average of 7.98%. The rise in short interest suggests bearish sentiment, but it doesn't guarantee a price drop.

Portfolio Pulse from Benzinga Insights

August 20, 2024 | 1:15 pm

VRAX

Virax Biolabs Group (NYSE:VRAX) has seen a significant decrease in its short percent of float, dropping by 54.22%. Currently, 1.03% of its shares are sold short, which is below the peer group average of 4.30%. This decrease in short interest may indicate a more bullish sentiment towards the stock.

Portfolio Pulse from Benzinga Insights

August 20, 2024 | 1:15 pm

ADBE

MSFT

Procreate's CEO announced a firm stance against integrating generative AI into their products, sparking discussions on digital art tools' future. This contrasts with companies like Adobe and Microsoft, which are embracing AI, potentially impacting their market strategies.

Portfolio Pulse from Benzinga Neuro

August 20, 2024 | 1:14 pm

NVDA

NVIDIA has announced its first digital human technologies with an on-device small language model aimed at enhancing conversations for game characters. This innovation is expected to improve the interactivity and realism of gaming experiences.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 1:13 pm

VMAR

Vision Marine Technologies has received a letter from Nasdaq indicating non-compliance with listing requirements. This could impact the company's stock price and investor confidence.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 1:11 pm